Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrated Personalized Diabetes Management (Integrated PDM): Prospective, Randomized, Controlled Intervention Study for the Evaluation of the Effectiveness and the Benefit of Integrated PDM in the Care of People With Type 2 Diabetes in Diabetes Specialized Medical Practices in Germany (DSP)

NCT02156349 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02156349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02156349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrated Personalized Diabetes Management (Integrated PDM): Prospective, Randomized, Controlled Intervention Study for the Evaluation of the Effectiveness and the Benefit of Integrated PDM in the Care of People With Type 2 Diabetes in Diabetes Specialized Medical Practices in Germany (DSP)
Lead sponsor
Hoffmann-La Roche
Phase
Not applicable
Overall status
Completed
Start date
May 14, 2014
Completion date
April 10, 2017
Enrollment
558 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

type ii diabetes mellitus